Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas
This study is currently recruiting participants.
Verified June 2011 by Trin Therapeutics GmbH
Study NCT01259518   Information provided by Trin Therapeutics GmbH

First Received on November 24, 2010.   Last Updated on June 6, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neoplasms
Additional conditions recognized in this trial
Sarcoma
More general conditions related to this trial
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Interventions listed in this trial
TRIN2755
Sponsors listed in this trial
Trin Therapeutics GmbH
University Hospital, Essen
Central European Society for Anticancer Drug Research
Assign Data Management and Biostatistics GmbH, Innsbruck, Austria


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services